Figure 6.
(a) Active GLP-1 concentration in plasma after subcutaneous injection for 25 days. (b) Magnification of the area between Days 6 and 25. GLP-1 solution (×), F(P1) containing GLP-1 (●), F(P1/D+PA40) containing GLP-1 (■), and F(P1/D+PA40) without GLP-1 (◆). The data are shown as the mean ± SD (n = 3–6). * p < 0.05 vs. F(P1) containing GLP-1.